BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thompson SG, Kienast J, Pyke SD, Haverkate F, van de Loo JC. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. N Engl J Med. 1995;332:635-641. [PMID: 7845427 DOI: 10.1056/nejm199503093321003] [Cited by in Crossref: 1071] [Cited by in F6Publishing: 130] [Article Influence: 41.2] [Reference Citation Analysis]
Number Citing Articles
1 Ansar W, Ghosh S. C-reactive protein and the biology of disease. Immunol Res. 2013;56:131-142. [PMID: 23371836 DOI: 10.1007/s12026-013-8384-0] [Cited by in Crossref: 158] [Cited by in F6Publishing: 126] [Article Influence: 19.8] [Reference Citation Analysis]
2 Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805-1812. [PMID: 12813013 DOI: 10.1172/jci18921] [Cited by in Crossref: 92] [Cited by in F6Publishing: 796] [Article Influence: 5.1] [Reference Citation Analysis]
3 Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J Clin Invest. 2003;111:1805-1812. [PMID: 12813013 DOI: 10.1172/jci200318921] [Cited by in Crossref: 2265] [Article Influence: 125.8] [Reference Citation Analysis]
4 Foy CA, Grant PJ. Genes and the development of vascular disease. Postgrad Med J 1997;73:271-8. [PMID: 9196698 DOI: 10.1136/pgmj.73.859.271] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
5 Kawano K, Yoshino H, Aoki N, Udagawa H, Watanuki A, Hioki Y, Hasumura Y, Yasumura T, Homori M, Murata M, Ikeda Y, Ishikawa K. Shear-induced platelet aggregation increases in patients with proximal and severe coronary artery stenosis. Clin Cardiol 2002;25:154-60. [PMID: 12000072 DOI: 10.1002/clc.4960250405] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
6 Lane HA, Smith JC, Davies JS. Noninvasive assessment of preclinical atherosclerosis. Vasc Health Risk Manag 2006;2:19-30. [PMID: 17319466 DOI: 10.2147/vhrm.2006.2.1.19] [Cited by in Crossref: 75] [Cited by in F6Publishing: 56] [Article Influence: 5.4] [Reference Citation Analysis]
7 Bertoluci MC, Cé GV, da Silva AM, Wainstein MV, Boff W, Puñales M. Endothelial dysfunction as a predictor of cardiovascular disease in type 1 diabetes. World J Diabetes 2015;6:679-92. [PMID: 26069717 DOI: 10.4239/wjd.v6.i5.679] [Cited by in CrossRef: 46] [Cited by in F6Publishing: 35] [Article Influence: 7.7] [Reference Citation Analysis]
8 Wei Y, Liu G, Yang J, Zheng R, Jiang L, Bao P. The association between metabolic syndrome and vascular endothelial dysfunction in adolescents. Exp Ther Med 2013;5:1663-6. [PMID: 23837050 DOI: 10.3892/etm.2013.1055] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
9 Heppell RM, Berkin KE, McLenachan JM, Davies JA. Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non-rheumatic atrial fibrillation. Heart 1997;77:407-11. [PMID: 9196408 DOI: 10.1136/hrt.77.5.407] [Cited by in Crossref: 156] [Cited by in F6Publishing: 113] [Article Influence: 6.5] [Reference Citation Analysis]
10 Russo I. The prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balance. Scientifica (Cairo). 2012;2012:525374. [PMID: 24278711 DOI: 10.6064/2012/525374] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
11 Dawood FZ, Judd S, Howard VJ, Limdi NA, Meschia JF, Cushman M, Howard G, Herrington DM, Soliman EZ. High-Sensitivity C-Reactive Protein and Risk of Stroke in Atrial Fibrillation (from the Reasons for Geographic and Racial Differences in Stroke Study). Am J Cardiol 2016;118:1826-30. [PMID: 27712649 DOI: 10.1016/j.amjcard.2016.08.069] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
12 Brennan ML, Reddy A, Tang WH, Wu Y, Brennan DM, Hsu A, Mann SA, Hammer PL, Hazen SL. Comprehensive peroxidase-based hematologic profiling for the prediction of 1-year myocardial infarction and death. Circulation 2010;122:70-9. [PMID: 20566956 DOI: 10.1161/CIRCULATIONAHA.109.881581] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.1] [Reference Citation Analysis]
13 Crea F, Monaco C, Lanza GA, Maggi E, Ginnetti F, Cianflone D, Niccoli G, Cook T, Bellomo G, Kjekshus J. Inflammatory predictors of mortality in the Scandinavian Simvastatin Survival Study. Clin Cardiol 2002;25:461-6. [PMID: 12375804 DOI: 10.1002/clc.4960251005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.0] [Reference Citation Analysis]
14 Etemadi A, Kamangar F, Islami F, Poustchi H, Pourshams A, Brennan P, Boffetta P, Malekzadeh R, Dawsey SM, Abnet CC, Emadi A. Mortality and cancer in relation to ABO blood group phenotypes in the Golestan Cohort Study. BMC Med 2015;13:8. [PMID: 25592833 DOI: 10.1186/s12916-014-0237-8] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 4.3] [Reference Citation Analysis]
15 Gunn M, Stephens JC, Thompson JR, Rathbone BJ, Samani NJ. Significant association of cagA positive Helicobacter pylori strains with risk of premature myocardial infarction. Heart 2000;84:267-71. [PMID: 10956287 DOI: 10.1136/heart.84.3.267] [Cited by in Crossref: 48] [Cited by in F6Publishing: 45] [Article Influence: 2.3] [Reference Citation Analysis]
16 Blum A, Kaplan G, Vardinon N, Yust I, Burke M, Laniado S, Miller H. Serum amyloid type A may be a predictor of restenosis. Clin Cardiol 1998;21:655-8. [PMID: 9755382 DOI: 10.1002/clc.4960210909] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
17 Hognestad A, Aukrust P, Wergeland R, Stokke O, Gullestad L, Semb AG, Holm T, Andreassen AK, Kjekshus JK. Effects of conventional and aggressive statin treatment on markers of endothelial function and inflammation. Clin Cardiol 2004;27:199-203. [PMID: 15119693 DOI: 10.1002/clc.4960270405] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
18 Urano T, Suzuki Y, Iwaki T, Sano H, Honkura N, Castellino FJ. Recognition of Plasminogen Activator Inhibitor Type 1 as the Primary Regulator of Fibrinolysis. Curr Drug Targets 2019;20:1695-701. [PMID: 31309890 DOI: 10.2174/1389450120666190715102510] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 13.0] [Reference Citation Analysis]
19 Ikonomidis I, Andreotti F, Nihoyannopoulos P. Reduction of daily life ischaemia by aspirin in patients with angina: underlying link between thromboxane A2 and macrophage colony stimulating factor. Heart 2004;90:389-93. [PMID: 15020512 DOI: 10.1136/hrt.2003.015164] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
20 Jia Z, Nallasamy P, Liu D, Shah H, Li JZ, Chitrakar R, Si H, McCormick J, Zhu H, Zhen W. Luteolin protects against vascular inflammation in mice and TNF-alpha-induced monocyte adhesion to endothelial cells via suppressing IΚBα/NF-κB signaling pathway. J Nutr Biochem. 2015;26:293-302. [PMID: 25577468 DOI: 10.1016/j.jnutbio.2014.11.008] [Cited by in Crossref: 81] [Cited by in F6Publishing: 72] [Article Influence: 11.6] [Reference Citation Analysis]
21 Ward-Caviness CK, Huffman JE, Everett K, Germain M, van Dongen J, Hill WD, Jhun MA, Brody JA, Ghanbari M, Du L, Roetker NS, de Vries PS, Waldenberger M, Gieger C, Wolf P, Prokisch H, Koenig W, O'Donnell CJ, Levy D, Liu C, Truong V, Wells PS, Trégouët DA, Tang W, Morrison AC, Boerwinkle E, Wiggins KL, McKnight B, Guo X, Psaty BM, Sotoodenia N, Boomsma DI, Willemsen G, Ligthart L, Deary IJ, Zhao W, Ware EB, Kardia SLR, Van Meurs JBJ, Uitterlinden AG, Franco OH, Eriksson P, Franco-Cereceda A, Pankow JS, Johnson AD, Gagnon F, Morange PE, de Geus EJC, Starr JM, Smith JA, Dehghan A, Björck HM, Smith NL, Peters A. DNA methylation age is associated with an altered hemostatic profile in a multiethnic meta-analysis. Blood 2018;132:1842-50. [PMID: 30042098 DOI: 10.1182/blood-2018-02-831347] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
22 Manzi S, Wasko MC. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis 2000;59:321-5. [PMID: 10784507 DOI: 10.1136/ard.59.5.321] [Cited by in Crossref: 124] [Cited by in F6Publishing: 103] [Article Influence: 5.9] [Reference Citation Analysis]
23 Ghoshal K, Bhattacharyya M. Overview of platelet physiology: its hemostatic and nonhemostatic role in disease pathogenesis. ScientificWorldJournal 2014;2014:781857. [PMID: 24729754 DOI: 10.1155/2014/781857] [Cited by in Crossref: 128] [Cited by in F6Publishing: 92] [Article Influence: 18.3] [Reference Citation Analysis]
24 Kannel WB. Overview of hemostatic factors involved in atherosclerotic cardiovascular disease. Lipids 2005;40:1215-20. [PMID: 16477805 DOI: 10.1007/s11745-005-1488-8] [Cited by in Crossref: 125] [Cited by in F6Publishing: 107] [Article Influence: 8.3] [Reference Citation Analysis]
25 Ramos JD, Casey MF, Crabb SJ, Bamias A, Harshman LC, Wong YN, Bellmunt J, De Giorgi U, Ladoire S, Powles T, Pal SK, Niegisch G, Recine F, Alva A, Agarwal N, Necchi A, Vaishampayan UN, Rosenberg JE, Galsky MD, Yu EY; RISC Investigators. Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival. Cancer Med 2017;6:186-94. [PMID: 28000388 DOI: 10.1002/cam4.986] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.6] [Reference Citation Analysis]
26 Aziz CB, Omar N, Abdullah WZ, Jalil RA, Nik WS, Zakaria R. Reduced fibrinogen, fibrinolytic biomarkers, and physical parameters after a weight-loss program in obese subjects. N Am J Med Sci 2014;6:377-82. [PMID: 25210670 DOI: 10.4103/1947-2714.139286] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
27 Jax TW, Peters AJ, Plehn G, Schoebel FC. Relevance of hemostatic risk factors on coronary morphology in patients with diabetes mellitus type 2. Cardiovasc Diabetol 2009;8:24. [PMID: 19419582 DOI: 10.1186/1475-2840-8-24] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
28 Darabos C, White MJ, Graham BE, Leung DN, Williams SM, Moore JH. The multiscale backbone of the human phenotype network based on biological pathways. BioData Min 2014;7:1. [PMID: 24460644 DOI: 10.1186/1756-0381-7-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
29 Scheja A, Akesson A, Geborek P, Wildt M, Wollheim CB, Wollheim FA, Vischer UM. Von Willebrand factor propeptide as a marker of disease activity in systemic sclerosis (scleroderma). Arthritis Res 2001;3:178-82. [PMID: 11299058 DOI: 10.1186/ar295] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 1.7] [Reference Citation Analysis]
30 Jia Z, Babu PV, Si H, Nallasamy P, Zhu H, Zhen W, Misra HP, Li Y, Liu D. Genistein inhibits TNF-α-induced endothelial inflammation through the protein kinase pathway A and improves vascular inflammation in C57BL/6 mice. Int J Cardiol 2013;168:2637-45. [PMID: 23587398 DOI: 10.1016/j.ijcard.2013.03.035] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 5.9] [Reference Citation Analysis]
31 Kalkman HO. The Association Between Vascular Inflammation and Depressive Disorder. Causality, Biomarkers and Targeted Treatment. Pharmaceuticals (Basel) 2020;13:E92. [PMID: 32408603 DOI: 10.3390/ph13050092] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
32 Jax TW, Peters AJ, Plehn G, Schoebel FC. Hemostatic risk factors in patients with coronary artery disease and type 2 diabetes - a two year follow-up of 243 patients. Cardiovasc Diabetol 2009;8:48. [PMID: 19735543 DOI: 10.1186/1475-2840-8-48] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 2.2] [Reference Citation Analysis]
33 Kim J, Amar S. Periodontal disease and systemic conditions: a bidirectional relationship. Odontology 2006;94:10-21. [PMID: 16998613 DOI: 10.1007/s10266-006-0060-6] [Cited by in Crossref: 259] [Cited by in F6Publishing: 186] [Article Influence: 17.3] [Reference Citation Analysis]
34 Liak C, Fitzpatrick M. Coagulability in obstructive sleep apnea. Can Respir J 2011;18:338-48. [PMID: 22187690 DOI: 10.1155/2011/924629] [Cited by in Crossref: 44] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
35 Womack CJ, Nagelkirk PR, Coughlin AM. Exercise-induced changes in coagulation and fibrinolysis in healthy populations and patients with cardiovascular disease. Sports Med 2003;33:795-807. [PMID: 12959620 DOI: 10.2165/00007256-200333110-00002] [Cited by in Crossref: 63] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
36 Khoury J, Henriksen T, Seljeflot I, Mørkrid L, Frøslie KF, Tonstad S. Effects of an antiatherogenic diet during pregnancy on markers of maternal and fetal endothelial activation and inflammation: the CARRDIP study. BJOG 2007;114:279-88. [PMID: 17217362 DOI: 10.1111/j.1471-0528.2006.01187.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
37 Phillips JE, Marsland AL, Flory JD, Muldoon MF, Cohen S, Manuck SB. Parental education is related to C-reactive protein among female middle-aged community volunteers. Brain Behav Immun 2009;23:677-83. [PMID: 19486653 DOI: 10.1016/j.bbi.2009.01.008] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 2.9] [Reference Citation Analysis]
38 Akamatsu Y, Nishijima Y, Lee CC, Yang SY, Shi L, An L, Wang RK, Tominaga T, Liu J. Impaired leptomeningeal collateral flow contributes to the poor outcome following experimental stroke in the Type 2 diabetic mice. J Neurosci 2015;35:3851-64. [PMID: 25740515 DOI: 10.1523/JNEUROSCI.3838-14.2015] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
39 Kremers RM, Mohamed AB, Pelkmans L, Hindawi S, Hemker HC, de Laat HB, Huskens D, Al Dieri R. Thrombin Generating Capacity and Phenotypic Association in ABO Blood Groups. PLoS One 2015;10:e0141491. [PMID: 26509437 DOI: 10.1371/journal.pone.0141491] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
40 Gibbs CR, Blann AD, Edmunds E, Watson RD, Lip GY. Effects of acute exercise on hemorheological, endothelial, and platelet markers in patients with chronic heart failure in sinus rhythm. Clin Cardiol 2001;24:724-9. [PMID: 11714130 DOI: 10.1002/clc.4960241107] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
41 Rodríguez-Hernández H, Simental-Mendía LE, Rodríguez-Ramírez G, Reyes-Romero MA. Obesity and inflammation: epidemiology, risk factors, and markers of inflammation. Int J Endocrinol 2013;2013:678159. [PMID: 23690772 DOI: 10.1155/2013/678159] [Cited by in Crossref: 182] [Cited by in F6Publishing: 145] [Article Influence: 22.8] [Reference Citation Analysis]
42 Musaad S, Haynes EN. Biomarkers of obesity and subsequent cardiovascular events. Epidemiol Rev 2007;29:98-114. [PMID: 17494057 DOI: 10.1093/epirev/mxm005] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 3.9] [Reference Citation Analysis]
43 Green D, Chan C, Kang J, Liu K, Schreiner P, Jenny NS, Tracy RP. Longitudinal assessment of fibrinogen in relation to subclinical cardiovascular disease: the CARDIA study. J Thromb Haemost 2010;8:489-95. [PMID: 20025644 DOI: 10.1111/j.1538-7836.2009.03727.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 2.3] [Reference Citation Analysis]
44 Chen JW, Gall MA, Deckert M, Jensen JS, Parving HH. Increased serum concentration of von Willebrand factor in non-insulin dependent diabetic patients with and without diabetic nephropathy. BMJ 1995;311:1405-6. [PMID: 8520276 DOI: 10.1136/bmj.311.7017.1405] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
45 Knowles JW, Maeda N. Genetic modifiers of atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2000;20:2336-45. [PMID: 11073835 DOI: 10.1161/01.atv.20.11.2336] [Cited by in Crossref: 94] [Cited by in F6Publishing: 33] [Article Influence: 4.5] [Reference Citation Analysis]
46 Gragnano F, Sperlongano S, Golia E, Natale F, Bianchi R, Crisci M, Fimiani F, Pariggiano I, Diana V, Carbone A, Cesaro A, Concilio C, Limongelli G, Russo M, Calabrò P. The Role of von Willebrand Factor in Vascular Inflammation: From Pathogenesis to Targeted Therapy. Mediators Inflamm 2017;2017:5620314. [PMID: 28634421 DOI: 10.1155/2017/5620314] [Cited by in Crossref: 83] [Cited by in F6Publishing: 68] [Article Influence: 20.8] [Reference Citation Analysis]
47 Feng D, Tracy RP, Lipinska I, Murillo J, McKenna C, Tofler GH. Effect of short-term aspirin use on C-reactive protein. J Thromb Thrombolysis 2000;9:37-41. [PMID: 10590187 DOI: 10.1023/a:1018644212794] [Cited by in Crossref: 59] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
48 Tarighi B, Kurum T, Demir M, Azcan SN. The effects of nebivolol on fibrinolytic parameters in mild and moderate hypertensive patients. Can J Cardiol 2007;23:651-5. [PMID: 17593991 DOI: 10.1016/s0828-282x(07)70227-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
49 Okhota S, Melnikov I, Avtaeva Y, Kozlov S, Gabbasov Z. Shear Stress-Induced Activation of von Willebrand Factor and Cardiovascular Pathology. Int J Mol Sci 2020;21:E7804. [PMID: 33096906 DOI: 10.3390/ijms21207804] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
50 Jansson JH, Nilsson TK, Johnson O. von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction. Heart 1998;80:334-7. [PMID: 9875107 DOI: 10.1136/hrt.80.4.334] [Cited by in Crossref: 72] [Cited by in F6Publishing: 59] [Article Influence: 3.3] [Reference Citation Analysis]
51 Rosenson RS. Non-lipid-lowering effects of statins on atherosclerosis. Curr Cardiol Rep 1999;1:225-32. [PMID: 10980846 DOI: 10.1007/s11886-999-0027-7] [Cited by in Crossref: 37] [Cited by in F6Publishing: 27] [Article Influence: 1.8] [Reference Citation Analysis]
52 Shirpoor A, Norouzi L, Nemati S, Khadem Ansari MH. Protective effect of vitamin E against diabetes-induced oxidized LDL and aorta cell wall proliferation in rat. Iran Biomed J 2015;19:117-23. [PMID: 25864817 DOI: 10.6091/ibj.1449.2015] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Cheung YF, Ho MH, Tam SC, Yung TC. Increased high sensitivity C reactive protein concentrations and increased arterial stiffness in children with a history of Kawasaki disease. Heart 2004;90:1281-5. [PMID: 15486121 DOI: 10.1136/hrt.2003.018507] [Cited by in Crossref: 52] [Cited by in F6Publishing: 43] [Article Influence: 3.1] [Reference Citation Analysis]
54 Schaefer U, Machida T, Vorlova S, Strickland S, Levi R. The plasminogen activator system modulates sympathetic nerve function. J Exp Med 2006;203:2191-200. [PMID: 16940168 DOI: 10.1084/jem.20060077] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
55 Lee KW, Blann AD, Ingram J, Jolly K, Lip GY; BRUM Investigators. Incremental shuttle walking is associated with activation of haemostatic and haemorheological markers in patients with coronary artery disease: the Birmingham rehabilitation uptake maximization study (BRUM). Heart 2005;91:1413-7. [PMID: 15774609 DOI: 10.1136/hrt.2004.050005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
56 Nallasamy P, Si H, Babu PV, Pan D, Fu Y, Brooke EA, Shah H, Zhen W, Zhu H, Liu D, Li Y, Jia Z. Sulforaphane reduces vascular inflammation in mice and prevents TNF-α-induced monocyte adhesion to primary endothelial cells through interfering with the NF-κB pathway. J Nutr Biochem 2014;25:824-33. [PMID: 24880493 DOI: 10.1016/j.jnutbio.2014.03.011] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 6.7] [Reference Citation Analysis]
57 Esper RJ, Nordaby RA, Vilariño JO, Paragano A, Cacharrón JL, Machado RA. Endothelial dysfunction: a comprehensive appraisal. Cardiovasc Diabetol 2006;5:4. [PMID: 16504104 DOI: 10.1186/1475-2840-5-4] [Cited by in Crossref: 243] [Cited by in F6Publishing: 195] [Article Influence: 16.2] [Reference Citation Analysis]
58 Li XH, Guan LY, Lin HY, Wang SH, Cao YQ, Jiang XY, Wang YB. Fibrinogen: A Marker in Predicting Diabetic Foot Ulcer Severity. J Diabetes Res 2016;2016:2358321. [PMID: 28044140 DOI: 10.1155/2016/2358321] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
59 Newby DE, Witherow FN, Wright RA, Bloomfield P, Ludlam CA, Boon NA, Fox KA, Webb DJ. Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo. Heart 2002;87:48-53. [PMID: 11751664 DOI: 10.1136/heart.87.1.48] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 0.9] [Reference Citation Analysis]
60 Blann A, Lip G. Assessment of endothelial function using plasma markers. Heart 1997;78:321-2. [PMID: 9391304 DOI: 10.1136/hrt.78.3.321] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
61 Salazar J, Martínez MS, Chávez M, Toledo A, Añez R, Torres Y, Apruzzese V, Silva C, Rojas J, Bermúdez V. C-reactive protein: clinical and epidemiological perspectives. Cardiol Res Pract 2014;2014:605810. [PMID: 24653858 DOI: 10.1155/2014/605810] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 7.4] [Reference Citation Analysis]
62 Shamsuzzaman A, Amin RS, Calvin AD, Davison D, Somers VK. Severity of obstructive sleep apnea is associated with elevated plasma fibrinogen in otherwise healthy patients. Sleep Breath 2014;18:761-6. [PMID: 24510497 DOI: 10.1007/s11325-014-0938-4] [Cited by in Crossref: 28] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
63 Cusack M, Redwood S, Coltart J. Recent advances in ischaemic heart disease. Postgrad Med J 2000;76:542-6. [PMID: 10964115 DOI: 10.1136/pmj.76.899.542] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
64 Rho R, Tracy RP, Bovill EG, Ball SP, Becker RC. Plasma Markers of Procoagulant Activity Among Individuals with Coronary Artery Disease. J Thromb Thrombolysis 1995;2:239-43. [PMID: 10608030 DOI: 10.1007/BF01062716] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
65 Castro JP, El-Atat FA, McFarlane SI, Aneja A, Sowers JR. Cardiometabolic syndrome: pathophysiology and treatment. Curr Hypertens Rep. 2003;5:393-401. [PMID: 12948432 DOI: 10.1007/s11906-003-0085-y] [Cited by in Crossref: 77] [Cited by in F6Publishing: 58] [Article Influence: 4.3] [Reference Citation Analysis]
66 Boots JM, Christiaans MH, van Hooff JP. Effect of immunosuppressive agents on long-term survival of renal transplant recipients: focus on the cardiovascular risk. Drugs. 2004;64:2047-2073. [PMID: 15341497 DOI: 10.2165/00003495-200464180-00004] [Cited by in Crossref: 100] [Cited by in F6Publishing: 80] [Article Influence: 5.9] [Reference Citation Analysis]
67 Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol. 2006;95:136-147. [PMID: 16598526 DOI: 10.1007/s00392-006-0351-5] [Cited by in Crossref: 269] [Cited by in F6Publishing: 222] [Article Influence: 17.9] [Reference Citation Analysis]
68 Warlo EMK, Pettersen AR, Arnesen H, Seljeflot I. vWF/ADAMTS13 is associated with on-aspirin residual platelet reactivity and clinical outcome in patients with stable coronary artery disease. Thromb J 2017;15:28. [PMID: 29200971 DOI: 10.1186/s12959-017-0151-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
69 Prandoni P. Venous and arterial thrombosis: Two aspects of the same disease? Clin Epidemiol 2009;1:1-6. [PMID: 20865079 DOI: 10.2147/clep.s4780] [Cited by in Crossref: 33] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
70 Rauch A, Wohner N, Christophe OD, Denis CV, Susen S, Lenting PJ. On the versatility of von Willebrand factor. Mediterr J Hematol Infect Dis 2013;5:e2013046. [PMID: 23936617 DOI: 10.4084/MJHID.2013.046] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 2.5] [Reference Citation Analysis]
71 Hirschfield GM, Gallimore JR, Kahan MC, Hutchinson WL, Sabin CA, Benson GM, Dhillon AP, Tennent GA, Pepys MB. Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A 2005;102:8309-14. [PMID: 15919817 DOI: 10.1073/pnas.0503202102] [Cited by in Crossref: 150] [Cited by in F6Publishing: 128] [Article Influence: 9.4] [Reference Citation Analysis]
72 Maseri A, Biasucci LM, Liuzzo G. Inflammation in ischaemic heart disease. BMJ 1996;312:1049-50. [PMID: 8616394 DOI: 10.1136/bmj.312.7038.1049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 1.6] [Reference Citation Analysis]
73 Yu Q, Lin Y, Yang P, Wang Y, Zhao S, Yang P, Fan J, Liu E. C-reactive protein is associated with the progression of acute embolic stroke in rabbit model. J Thromb Thrombolysis 2012;33:301-7. [PMID: 21874402 DOI: 10.1007/s11239-011-0627-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
74 Shojaie M, Sotoodah A, Roozmeh S, Kholoosi E, Dana S. Annexin V and anti-Annexin V antibodies: two interesting aspects in acute myocardial infarction. Thromb J 2009;7:13. [PMID: 19622170 DOI: 10.1186/1477-9560-7-13] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
75 Muuronen AT, Taina M, Onatsu J, Korhonen M, Pulkki K, Jäkälä P, Vanninen R, Mustonen P. vWF correlates with visceral and pericardial adipose tissue in patients with a recent stroke of suspected cardiogenic etiology. PLoS One 2017;12:e0178508. [PMID: 28570705 DOI: 10.1371/journal.pone.0178508] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
76 Otto C, Parhofer KG, Ritter MM, Richter WO, Schwandt P. Effects of acipimox on haemorheology and plasma lipoproteins in patients with mixed hyperlipoproteinaemia. Br J Clin Pharmacol 1998;46:473-8. [PMID: 9833601 DOI: 10.1046/j.1365-2125.1998.00816.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
77 Green D, Foiles N, Chan C, Schreiner PJ, Liu K. Elevated fibrinogen levels and subsequent subclinical atherosclerosis: the CARDIA Study. Atherosclerosis 2009;202:623-31. [PMID: 18602107 DOI: 10.1016/j.atherosclerosis.2008.05.039] [Cited by in Crossref: 71] [Cited by in F6Publishing: 59] [Article Influence: 5.5] [Reference Citation Analysis]
78 Schoebel FC, Jax TW, Fischer Y, Strauer BE, Leschke M. Antithrombotic treatment in stable coronary syndromes: long-term intermittent urokinase therapy in end-stage coronary artery disease and refractory angina pectoris. Heart 1997;77:13-7. [PMID: 9038688 DOI: 10.1136/hrt.77.1.13] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
79 Hong YJ, Jeong MH, Park OY, Kim W, Kim JH, Ahn YK, Cho JG, Ahn BH, Suh SP, Park JC, Kim SH, Kang JC. The role of C-reactive protein on the long-term clinical outcome after primary or rescue percutaneous coronary intervention. Korean J Intern Med 2003;18:29-34. [PMID: 12760265 DOI: 10.3904/kjim.2003.18.1.29] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
80 Aleksic N, Wang YW, Ahn C, Juneja HS, Folsom AR, Wu KK. Assessment of coronary heart disease risk by combined analysis of coagulation factors. Atherosclerosis 2008;198:294-300. [PMID: 18342864 DOI: 10.1016/j.atherosclerosis.2007.12.062] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
81 Bots ML, Elwood PC, Salonen JT, Freire de Concalves A, Sivenius J, Di Carlo A, Nikitin Y, Benetou V, Tuomilehto J, Koudstaal PJ, Grobbee DE. Level of fibrinogen and risk of fatal and non-fatal stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 2002;56 Suppl 1:i14-8. [PMID: 11815639 DOI: 10.1136/jech.56.suppl_1.i14] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
82 Ryu R, Kim HJ, Moon B, Jung UJ, Lee MK, Lee DG, Ryoo Z, Park YB, Choi MS. Ethanol Extract of Persimmon Tree Leaves Improves Blood Circulation and Lipid Metabolism in Rats Fed a High-Fat Diet. J Med Food 2015;18:715-23. [PMID: 26061228 DOI: 10.1089/jmf.2014.3307] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
83 Nakagawa H, Tamura T, Mitsuda Y, Goto Y, Kamiya Y, Kondo T, Wakai K, Hamajima N. Significant association between serum interleukin-6 and Helicobacter pylori antibody levels among H. pylori-positive Japanese adults. Mediators Inflamm. 2013;2013:142358. [PMID: 24453409 DOI: 10.1155/2013/142358] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
84 Milionis HJ, Winder AF, Mikhailidis DP. Lipoprotein (a) and stroke. J Clin Pathol 2000;53:487-96. [PMID: 10961170 DOI: 10.1136/jcp.53.7.487] [Cited by in Crossref: 69] [Cited by in F6Publishing: 62] [Article Influence: 3.3] [Reference Citation Analysis]
85 Toraldo DM, De Benedetto M, Scoditti E, De Nuccio F. Obstructive sleep apnea syndrome: coagulation anomalies and treatment with continuous positive airway pressure. Sleep Breath 2016;20:457-65. [PMID: 26169715 DOI: 10.1007/s11325-015-1227-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
86 Siegler JE, Samai A, Albright KC, Boehme AK, Martin-Schild S. Factoring in Factor VIII With Acute Ischemic Stroke. Clin Appl Thromb Hemost 2015;21:597-602. [PMID: 25669199 DOI: 10.1177/1076029615571630] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
87 Khafaji HA, Bener A, Osman M, Al Merri A, Al Suwaidi J. The impact of diurnal fasting during Ramadan on the lipid profile, hs-CRP, and serum leptin in stable cardiac patients. Vasc Health Risk Manag 2012;8:7-14. [PMID: 22272070 DOI: 10.2147/VHRM.S22894] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 0.7] [Reference Citation Analysis]
88 Pilote L, Dasgupta K, Guru V, Humphries KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T, Cox J, Ghali WA, Grace S, Hamet P, Ho T, Kirkland S, Lambert M, Libersan D, O'Loughlin J, Paradis G, Petrovich M, Tagalakis V. A comprehensive view of sex-specific issues related to cardiovascular disease. CMAJ 2007;176:S1-44. [PMID: 17353516 DOI: 10.1503/cmaj.051455] [Cited by in Crossref: 261] [Cited by in F6Publishing: 191] [Article Influence: 18.6] [Reference Citation Analysis]
89 Parastatidis I, Thomson L, Burke A, Chernysh I, Nagaswami C, Visser J, Stamer S, Liebler DC, Koliakos G, Heijnen HF, Fitzgerald GA, Weisel JW, Ischiropoulos H. Fibrinogen beta-chain tyrosine nitration is a prothrombotic risk factor. J Biol Chem 2008;283:33846-53. [PMID: 18818200 DOI: 10.1074/jbc.M805522200] [Cited by in Crossref: 63] [Cited by in F6Publishing: 24] [Article Influence: 4.8] [Reference Citation Analysis]
90 O'Callaghan ME, MacLennan AH, Haan EA, Dekker G; South Australian Cerebral Palsy Research Group. The genomic basis of cerebral palsy: a HuGE systematic literature review. Hum Genet 2009;126:149-72. [PMID: 19238444 DOI: 10.1007/s00439-009-0638-5] [Cited by in Crossref: 43] [Cited by in F6Publishing: 31] [Article Influence: 3.6] [Reference Citation Analysis]
91 Zouaoui Boudjeltia K, Daher J, Van Antwerpen P, Moguilevsky N, Delree P, Ducobu J, Raes M, Badran B, Vanhaeverbeek M, Brohee D, Remacle C, Vanhamme L. Exposure of endothelial cells to physiological levels of myeloperoxidase-modified LDL delays pericellular fibrinolysis. PLoS One 2012;7:e38810. [PMID: 22723891 DOI: 10.1371/journal.pone.0038810] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
92 Bakhru A, Erlinger TP. Smoking cessation and cardiovascular disease risk factors: results from the Third National Health and Nutrition Examination Survey. PLoS Med 2005;2:e160. [PMID: 15974805 DOI: 10.1371/journal.pmed.0020160] [Cited by in Crossref: 132] [Cited by in F6Publishing: 101] [Article Influence: 8.3] [Reference Citation Analysis]
93 Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996;312:1061-1065. [PMID: 8616412 DOI: 10.1136/bmj.312.7038.1061] [Cited by in Crossref: 569] [Cited by in F6Publishing: 503] [Article Influence: 22.8] [Reference Citation Analysis]
94 Oguzulgen IK, Ekim N, Erkekol FO, Altinok B, Akar N. Is tissue-plasminogen activator gene polymorphism a risk factor for venous thromboembolism in every population? J Thromb Thrombolysis 2005;19:61-3. [PMID: 15976969 DOI: 10.1007/s11239-005-0941-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
95 Lee KW, Blann AD, Jolly K, Lip GY; BRUM Investigators. Plasma haemostatic markers, endothelial function and ambulatory blood pressure changes with home versus hospital cardiac rehabilitation: the Birmingham Rehabilitation Uptake Maximisation Study. Heart 2006;92:1732-8. [PMID: 16807272 DOI: 10.1136/hrt.2006.092163] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
96 Peng H, Yeh F, Lin J, Best LG, Cole SA, Lee ET, Howard BV, Zhao J. Plasminogen activator inhibitor-1 is associated with leukocyte telomere length in American Indians: findings from the Strong Heart Family Study. J Thromb Haemost 2017;15:1078-85. [PMID: 28378522 DOI: 10.1111/jth.13689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
97 Wilson PW. Assessing coronary heart disease risk with traditional and novel risk factors. Clin Cardiol 2004;27:III7-11. [PMID: 15239485 DOI: 10.1002/clc.4960271504] [Cited by in Crossref: 27] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
98 Figueras J, Monasterio J, Domingo E, Meneses B, Nieto E, Cortadellas J, Garcia-Dorado D. Prothrombotic profile in patients with vasospastic or non vasospastic angina and non significant coronary stenosis. Thromb J 2011;9:10. [PMID: 21619612 DOI: 10.1186/1477-9560-9-10] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
99 Azuma RW, Kadowaki T, El-Saed A, Ueshima H, Sutton-Tyrrell K, Nakamura Y, Edmundowicz D, Ueno Y, Evans RW, Kadota A, Kuller LH, Murata K, Takamiya T, Kadowaki S, Curb JD, Sekikawa A. Associations of D-dimer and von Willebrand factor with atherosclerosis in Japanese and white men. Acta Cardiol 2010;65:449-56. [PMID: 20821938 DOI: 10.2143/AC.65.4.2053904] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
100 Hoşgör I, Yarat A, Tüzüner N, Alkan F, Emekli N, Ahmad S. Biochemical and morphological alterations in lungs induced by experimental inhibition of fibrinolytic activity. Mol Cell Biochem 2002;241:9-19. [PMID: 12482020 DOI: 10.1023/a:1020822801712] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
101 Song J, Huang S, Wang K, Li W, Pao L, Chen F, Zhao X. Long Non-coding RNA MEG3 Attenuates the Angiotensin II-Induced Injury of Human Umbilical Vein Endothelial Cells by Interacting With p53. Front Genet 2019;10:78. [PMID: 30838022 DOI: 10.3389/fgene.2019.00078] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
102 Ahmed MS, Jadhav AB, Hassan A, Meng QH. Acute phase reactants as novel predictors of cardiovascular disease. ISRN Inflamm 2012;2012:953461. [PMID: 24049653 DOI: 10.5402/2012/953461] [Cited by in Crossref: 36] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
103 Ang L, Behnamfar O, Palakodeti S, Lin F, Pourdjabbar A, Patel MP, Reeves RR, Mahmud E. Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. J Am Heart Assoc 2017;6:e006580. [PMID: 29151032 DOI: 10.1161/JAHA.117.006580] [Cited by in Crossref: 13] [Cited by in F6Publishing: 4] [Article Influence: 3.3] [Reference Citation Analysis]
104 Singhal RK, Rai B. sTNF-R Levels: Apical Periodontitis Linked to Coronary Heart Disease. Open Access Maced J Med Sci 2017;5:68-71. [PMID: 28293320 DOI: 10.3889/oamjms.2017.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
105 Delfino RJ, Sioutas C, Malik S. Potential role of ultrafine particles in associations between airborne particle mass and cardiovascular health. Environ Health Perspect 2005;113:934-46. [PMID: 16079061 DOI: 10.1289/ehp.7938] [Cited by in Crossref: 607] [Cited by in F6Publishing: 420] [Article Influence: 40.5] [Reference Citation Analysis]
106 Labarrere CA, Woods JR, Hardin JW, Jaeger BR, Zembala M, Deng MC, Kassab GS. Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients. PLoS One 2014;9:e113260. [PMID: 25490200 DOI: 10.1371/journal.pone.0113260] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
107 Kato Y, Iwata A, Futami M, Yamashita M, Imaizumi S, Kuwano T, Ike A, Sugihara M, Nishikawa H, Zhang B, Yasunaga S, Saku K, Miura SI. Impact of von Willebrand factor on coronary plaque burden in coronary artery disease patients treated with statins. Medicine (Baltimore) 2018;97:e0589. [PMID: 29703054 DOI: 10.1097/MD.0000000000010589] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
108 Skinner JS, Farrer M, Albers CJ, Neil HA, Adams PC. High apolipoprotein AI concentrations are associated with lower mortality and myocardial infarction five years after coronary artery bypass graft surgery. Heart 1999;81:488-94. [PMID: 10212166 DOI: 10.1136/hrt.81.5.488] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
109 G RK, K MS, G KK, Kurapati M, M S, T MA, P C, G SR, S N, P K, K SS, H SR. Evaluation of Hs-CRP levels and interleukin 18 (-137G/C) promoter polymorphism in risk prediction of coronary artery disease in first degree relatives. PLoS One 2015;10:e0120359. [PMID: 25822970 DOI: 10.1371/journal.pone.0120359] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 1.8] [Reference Citation Analysis]
110 Rinde LB, Småbrekke B, Hald EM, Brodin EE, Njølstad I, Mathiesen EB, Løchen ML, Wilsgaard T, Brækkan SK, Vik A, Hansen JB. Myocardial infarction and future risk of cancer in the general population-the Tromsø Study. Eur J Epidemiol 2017;32:193-201. [PMID: 28176141 DOI: 10.1007/s10654-017-0231-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 14] [Article Influence: 5.8] [Reference Citation Analysis]
111 Shavadia JS, Granger CB, Alemayehu W, Westerhout CM, Povsic TJ, Van Diepen S, Defilippi C, Armstrong PW. Novel Biomarkers, ST-Elevation Resolution, and Clinical Outcomes Following Primary Percutaneous Coronary Intervention. J Am Heart Assoc 2020;9:e016033. [PMID: 32552321 DOI: 10.1161/JAHA.120.016033] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Han S, Wu H, Li W, Gao P. Protective effects of genistein in homocysteine-induced endothelial cell inflammatory injury. Mol Cell Biochem 2015;403:43-9. [PMID: 25626894 DOI: 10.1007/s11010-015-2335-0] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 7.5] [Reference Citation Analysis]
113 Weir RA, Balmain S, Steedman T, Ng LL, Squire IB, Rumley A, Dargie HJ, Lowe GD. Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction. J Thromb Thrombolysis 2010;29:421-8. [PMID: 19662337 DOI: 10.1007/s11239-009-0383-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
114 Zhu Q, Yamakuchi M, Ture S, de la Luz Garcia-Hernandez M, Ko KA, Modjeski KL, LoMonaco MB, Johnson AD, O'Donnell CJ, Takai Y, Morrell CN, Lowenstein CJ. Syntaxin-binding protein STXBP5 inhibits endothelial exocytosis and promotes platelet secretion. J Clin Invest 2014;124:4503-16. [PMID: 25244095 DOI: 10.1172/JCI71245] [Cited by in Crossref: 49] [Cited by in F6Publishing: 32] [Article Influence: 7.0] [Reference Citation Analysis]
115 Jousilahti P, Salomaa V, Rasi V, Vahtera E, Palosuo T. Association of markers of systemic inflammation, C reactive protein, serum amyloid A, and fibrinogen, with socioeconomic status. J Epidemiol Community Health 2003;57:730-3. [PMID: 12933781 DOI: 10.1136/jech.57.9.730] [Cited by in Crossref: 94] [Cited by in F6Publishing: 79] [Article Influence: 5.2] [Reference Citation Analysis]
116 Oliveira GH. Novel serologic markers of cardiovascular risk. Curr Atheroscler Rep 2005;7:148-54. [PMID: 15727731 DOI: 10.1007/s11883-005-0038-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
117 Zhu Q, Yamakuchi M, Lowenstein CJ. SNAP23 Regulates Endothelial Exocytosis of von Willebrand Factor. PLoS One 2015;10:e0118737. [PMID: 26266817 DOI: 10.1371/journal.pone.0118737] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
118 Harmanci O, Buyukasik Y, Kirazli S, Balkanci F, Bayraktar Y. Does endothelium agree with the concept of idiopathic hepatic vessel thrombosis? World J Gastroenterol 2006;12:1273-7. [PMID: 16534884 DOI: 10.3748/wjg.v12.i8.1273] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.1] [Reference Citation Analysis]
119 Patelis N, Karaolanis G, Kouvelos GN, Hart C, Metheiken S. The effect of exercise on coagulation and fibrinolysis factors in patients with peripheral arterial disease. Exp Biol Med (Maywood) 2016;241:1699-707. [PMID: 27444152 DOI: 10.1177/1535370216660215] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
120 Albert MA, Ridker PM. The role of C-reactive protein in cardiovascular disease risk. Curr Cardiol Rep 1999;1:99-104. [PMID: 10980827 DOI: 10.1007/s11886-999-0066-0] [Cited by in Crossref: 46] [Cited by in F6Publishing: 41] [Article Influence: 2.2] [Reference Citation Analysis]
121 Urano T, Castellino FJ, Suzuki Y. Regulation of plasminogen activation on cell surfaces and fibrin. J Thromb Haemost 2018. [PMID: 29779246 DOI: 10.1111/jth.14157] [Cited by in Crossref: 43] [Cited by in F6Publishing: 33] [Article Influence: 14.3] [Reference Citation Analysis]
122 Akşit E, Kurt T, Büyük B, Çokkalender Ö. Drug-eluting Vein Graft with Acetylsalicylic Acid-Ticagrelor-Unfractionated Heparin Complex Inhibits Early Graft Thrombosis. Balkan Med J 2020;37:269-75. [PMID: 32353222 DOI: 10.4274/balkanmedj.galenos.2020.2020.1.128] [Reference Citation Analysis]
123 Calabrò P, Golia E, Yeh ET. CRP and the risk of atherosclerotic events. Semin Immunopathol. 2009;31:79-94. [PMID: 19415283 DOI: 10.1007/s00281-009-0149-4] [Cited by in Crossref: 67] [Cited by in F6Publishing: 47] [Article Influence: 5.6] [Reference Citation Analysis]
124 Atar I, Gülmez O, Atar A, Bozbas H, Yildirir A, Ozin B, Korkmaz ME, Müderrisoglu H. The effects of prior beta-blocker therapy on serum C-reactive protein levels after percutaneous coronary intervention. Clin Cardiol 2005;28:243-6. [PMID: 15971460 DOI: 10.1002/clc.4960280509] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
125 Gebara OC, Mittleman MA, Walsh BW, Lipinska I, Welty FK, Bellotti G, Muller JE, Sacks FK, Tofler GH. Fibrinolytic potential is significantly increased by oestrogen treatment in postmenopausal women with mild dyslipidaemia. Heart 1998;80:235-9. [PMID: 9875081 DOI: 10.1136/hrt.80.3.235] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
126 Bernstein LE, Berry J, Kim S, Canavan B, Grinspoon SK. Effects of etanercept in patients with the metabolic syndrome. Arch Intern Med. 2006;166:902-908. [PMID: 16636217 DOI: 10.1001/archinte.166.8.902] [Cited by in Crossref: 169] [Cited by in F6Publishing: 151] [Article Influence: 11.3] [Reference Citation Analysis]
127 Hemmat N, Ebadi A, Badalzadeh R, Memar MY, Baghi HB. Viral infection and atherosclerosis. Eur J Clin Microbiol Infect Dis 2018;37:2225-33. [PMID: 30187247 DOI: 10.1007/s10096-018-3370-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
128 Morshed G, Fathy SM. Impact of post-laparoscopic sleeve gastrectomy weight loss on C-reactive protein, lipid profile and CA-125 in morbidly obese women. Wideochir Inne Tech Maloinwazyjne 2016;10:521-6. [PMID: 26865887 DOI: 10.5114/wiitm.2015.56480] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
129 Cesari M, Pahor M, Incalzi RA. Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. Cardiovasc Ther 2010;28:e72-91. [PMID: 20626406 DOI: 10.1111/j.1755-5922.2010.00171.x] [Cited by in Crossref: 202] [Cited by in F6Publishing: 157] [Article Influence: 18.4] [Reference Citation Analysis]
130 Shakouri P, Nezami N, Tarzamni MK, Rashid RJ. The elusive link between high sensitivity C-reactive protein and carotid subclinical atherosclerosis in coronary artery bypass grafting candidates: a cross-sectional study. Cardiovasc Ultrasound 2008;6:23. [PMID: 18513415 DOI: 10.1186/1476-7120-6-23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]